IITDLogo
Bacteriophage research and therapy - Our Institute's publications
  1. The Effect of Bacteriophage Preparations on Intracellular Killing of Bacteria by Phagocytes, Ewa Jończyk-Matysiak, Marzanna Łusiak-Szelachowska, Marlena Kłak, Barbara Bubak, Ryszard Międzybrodzki, Beata Weber-Dąbrowska, Maciej Żaczek, Wojciech Fortuna, Paweł Rogóż, Sławomir Letkiewicz, Krzysztof Szufnarowski, Andrzej Górski, J Immunol Res  2015, Article ID 482863
  2. T4 bacteriophage-mediated inhibition of adsorption and replication of human adenovirus in vitro, M. Przybylski, J.Borysowski, R. Jakubowska-Zahorska, B. Weber-Dąbrowska, A. Górski, Future Microbiol 2015,10,453-60
  3. Phages targeting infected tissues: novel approach to phage therapy, A. Górski, K. Dąbrowska, K. Hodyra-Stefaniak, J. Borysowski, R. Międzybrodzki, B.Weber – Dąbrowska, Future Microbiology 2015,10,199-204
  4. Phages in the global fruit and vegetable industry, M. Zaczek, B. Weber-Dabrowska, A. Gorski, J Appl Microbiol 2015,118,537-56
  5. Influence of bacteriophage preparations on migratory activity of human granulocytes in vitro, Kurzępa-Skaradzińska A., Skaradziński G., Troszok A., Weber-Dąbrowska B., Żaczek M., Maj T., Sławek A., Rymowicz W., Górski A. In: Industrial, medical and environmental applications of microorganisms: current status and trends. ed. Méndez-Vilas A. pp. 529-534. Wageningen Academic Publishers 2014
  6. Molecular and Chemical Engineering of Bacteriophages for Potential Medical Applications, Hodyra K, Dąbrowska K., Arch Immunol Ther Exp (Warsz). 2014 Jul 22
  7. T4 bacteriophage as a phage display platform, Gamkrelidze M, Dąbrowska K., Arch Microbiol. 2014 Jul;196(7):473-9
  8. Immunogenicity studies of proteins forming the T4 phage head surface, Dąbrowska K, Miernikiewicz P, Piotrowicz A, Hodyra K, Owczarek B, Lecion D, Kaźmierczak Z, Letarov A, Górski A., J Virol. 2014, 88, 12551-7
  9. Possible Use of Bacteriophages Active against Bacillus anthracis and Other B. cereus Group Members in the Face of a Bioterrorism Threat, Ewa Jonczyk-Matysiak, Marlena Klak, Beata Weber-Dąbrowska, Jan Borysowski, Andrzej Górski, Biomed Res Intl, vol. 2014, Article ID 735413, 2014. doi:10.1155/2014/735413
  10. Facing antibiotic resistance: staphylococcal phages as a medical tool, Zuzanna Kaźmierczak, Andrzej Górski, Krystyna Dąbrowska, Viruses 2014,6,2551-70
  11. In vitro design of a novel lytic bacteriophage cocktail with therapeutic potential against organisms causing diabetic foot infections, Mendes JJ, Leandro C, Mottola C, Barbosa R, Silva FA, Oliveira M, Vilela CL, Melo-Cristino J, Górski A, Pimentel M, São-José C, Cavaco-Silva P, Garcia M., J Med Microbiol. 2014 Aug;63(Pt 8):1055-65
  12. Bacteriophages displaying anticancer peptides in combined antibacterial and anticancer treatment, Dąbrowska K, Kaźmierczak Z, Majewska J, Miernikiewicz P, Piotrowicz A, Wietrzyk J, Lecion D, Hodyra K, Nasulewicz-Goldeman A, Owczarek B, Górski A., Future Microbiol. 2014 Jul;9:861-9
  13. Phage Therapy: Current Research and Applications, Edited by: Jan Borysowski, Ryszard Miedzybrodzki and Andrzej Górski, Caister Academic Press, Hardback: ISBN 978-1-908230-40-9 April 2014, Ebook: ISBN 978-1-908230-74-4 March 2014
    Downoad flyer
  14. Taking Bacteriophage Therapy Seriously, A Moral Argument, Verbeken G, Huys I, Pirnay JP, Jennes S, Chanishvili N, Scheres J, Górski A, De Vos D, Ceulemans C., Biomed Res Int. 2014;2014:621316
  15. Phage Neutralization by Sera of Patients Receiving Phage Therapy, Łusiak-Szelachowska M., Żaczek M., Weber-Dąbrowska B., Międzybrodzki R., Kłak M., Fortuna W., Letkiewicz S., Rogóż P., Szufnarowski K., Jończyk-Matysiak E., Owczarek B., Górski A., Viral Immunol. 2014 Aug;27(6):295-304
  16. Molecular imaging of T4 phage in mammalian tissues and cells, Zuzanna Kaźmierczak, Agnieszka Piotrowicz, Barbara Owczarek, Katarzyna Hodyra, Paulina Miernikiewicz, Dorota Lecion, Marek Harhala, Andrzej Górski, Krystyna Dąbrowska, Bacteriophage 2014 Jan 1;4(1):e28364. Epub 2014 Feb 27
  17. Bacteriophages in green biotechnology - the utilization of drinking water, Weber-Dąbrowska B., Żaczek M., Dziedzic B., Łusiak-Szelachowska M., Kiejzik M., Górski A., Gworek B., Wierzbicki K., Eymontt A. In: Industrial, medical and environmental applications of microorganisms: current status and trends. ed. Méndez-Vilas A. pp. 500-504. Wageningen Academic Publishers 2014
  18. A novel approach for separating bacteriophages from other bacteriophages using affinity chromatography and phage display, Izabela Ceglarek, Agnieszka Piotrowicz, Dorota Lecion, Paulina Miernikiewicz, Barbara Owczarek, Katarzyna Hodyra, Marek Harhala, Andrzej Górski & Krystyna Dąbrowska, Sci Rep. 2013 Nov 14;3:3220. doi: 10.1038/srep03220
  19. T4 phage and its head surface proteins do not stimulate inflammatory mediator production, Miernikiewicz P, Dąbrowska K, Piotrowicz A, Owczarek B, Wojas-Turek J, Kicielińska J, Rossowska J, Pajtasz-Piasecka E, Hodyra K, Macegoniuk K, Rzewucka K, Kopciuch A, Majka T, Letarov A, Kulikov E, Maciejewski H, Górski A., PLoS One. 2013 Aug 16;8(8):e71036. 2013
  20. Characterising the biology of novel lytic bacteriophages infecting multidrug resistant Klebsiella pneumoniae, Kęsik-Szeloch A, Drulis-Kawa Z, Weber-Dąbrowska B, Kassner J, Majkowska-Skrobek G, Augustyniak D, Łusiak-Szelachowska M, Żaczek M, Górski A, Kropinski M A., Virol J. 2013 Mar 28;10(1):100
  21. Application of microbiological quantitative methods for evaluation of changes in the amount of bacteria in patients with wounds and purulent fistulas subjected to phage therapy and for assessment of phage preparation effectiveness (in vitro studies), Dorota Lecion, Wojciech Fortuna, Krystyna Dąbrowska, Ryszard Międzybrodzki, Beata Weber-Dąbrowska, Andrzej Górski, Adv Med Sci 2013;58,:257-64
  22. Influence of bacteriophage preparations on migration of Hl-60 leukemia cells in vitro, A.Kurzępa-Skaradzińska, G.Skaradziński, B.Weber-Dąbrowska, M.Zaczek, T.Maj, A.Sławek, M. Switalska, M.Maciejska, J.Wietrzyk, W.Rymowicz, A.Górski, Anticancer Res 2013, 33,1569-74
  23. Influence of bacteriophage preparations on intracellular killing of bacteria by human phagocytes in vitro, Kurzępa-Skaradzińska A, Łusiak-Szelachowska M, Skaradziński G, Jończyk-Matysiak E, Weber-Dąbrowska B, Żaczek M, Maj T, Sławek A, Rymowicz W, Kłak M, Międzybrodzki R, Górski A., Viral Immunol. 2013 Apr;26(2):150-62
  24. Wound healing potential of topical bacteriophage therapy on diabetic cutaneous wounds, Mendes JJ, Leandro C, Corte-Real S, Barbosa R, Cavaco-Silva P, Melo-Cristino J, Górski A, Garcia M., Wound Repair Regen. 2013,21:595-603
  25. Clinical aspects of phage therapy, R.Międzybrodzki, J.Borysowski, B.Weber-Dąbrowska, W.Fortuna, S. Letkiewicz, K. Szufnarowski, Z.Pawełczyk, P. Rogóż, M.Kłak, E.Wojtasik, A.Górski, Adv Virus Res 2012, 83,73-121
  26. Phage as a modulator of immune responses: practical implications for phage therapy, A.Górski, R.Międzybrodzki, J.Borysowski, K. Dąbrowska, P.Wierzbicki, M.Ohams, G.Korczak-Kowalska, N.Olszowska-Zaremba, M.Łusiak-Szelachowska, M.Kłak, E.Jończyk, E.Kaniuga, A.Gołaś, S. Purchla, B.Weber-Dąbrowska, S.Letkiewicz, W.Fortuna, K.Szufnarowski, Z.Pawelczyk, P.Rogoż, D.Kłosowska,  Adv Virus Res 2012, 83,41-71
  27. Phage Translocation, Safety, and Immunomodulation, N.Olszowska-Zaremba, J.Borysowski, K.Dąbrowska, A.Górski
    In: Hyman, P., Abedon, S. T. (eds). Bacteriophages in Health and Disease. CABI Press, Wallingford, UK, 2012
  28. Potential of bacteriophages and their lysins in the treatment of MRSA - current status and future perspectives, J.Borysowski, M.Łobocka, R.Międzybrodzki, B.Weber-Dąbrwska, A.Górski, Biodrugs 2011,25,347-355 (leading article)
  29. Purification of phage display-modified bacteriophage T4 by affinity chromatography, A.Oslizlo, P.Miernikiewicz, A.Piotrowicz, B.Owczarek, A.Kopciuch, G.Figura, K.Dabrowska,
    BMC Biotechnol. 2011,11,59
  30. The influence of external factors on bacteriophages--review, E.Jończyk, M.Kłak, R.Międzybrodzki, A.Górski, Folia Microbiol 2011,56,191-200
  31. The Phage Therapy Paradigm: « Prêt à Porter » or « Sur-mesure » ?, Jean-Paul Pirnay, Daniel De Vos, Gilbert Verbeken, Maia Merabishvili, Mario Vaneechoutte, Martin Zizi, Geert Laire, Rob Lavigne, Isabelle Huys, Guy Van den Mooter, Angus Buckling, Laurent Debarbieux, Flavie Pouillot, Joana Azeredo, Elizabeth Kutter, Alain Dublanchet, Andrzej Górski, Revaz Adamia,  Pharmaceutical Research 2011,28,934-7
  32. The effects of T4 and A3/R phage preparations on whole-blood monocyte and neutrophil respiratory burst, Borysowski J, Wierzbicki P, Kłosowska D, Korczak-Kowalska G, Weber-Dabrowska B, Górski A. Viral Immunol 2010,23,541-4
    www.ncbi.nlm.nih.gov/pubmed/20883168
  33. The perspectives of the application of phage therapy in chronic bacterial prostatitis, S.Letkiewicz, R.Międzybrodzki, M.Kłak, E.Jonczyk, B.Weber-Dąbrowska, A.Górski, FEMS Immunol.Med.Microbiol. 2010, 60,99-112
  34. Bacteriophages and cancer, P.Budynek, K.Dąbrowska, G.Skaradziński, A.Górski, Archives of Microbiology 2010,192,315-20
  35. Enzybiotics and their potential applications in medicine, J.Borysowski, A.Górski, In: Enzybiotics Enzymes as drugs and therapeutics, pp 1-26. TG Villa, P. Veiga-Crespo, eds., Wiley & Sons, 2010.
  36. Anti-staphylococcal lytic enzymes, J.Borysowski, A.Górski, In: Enzybiotics Enzymes as drugs and therapeutics, pp 149-172. TG Villa, P. Veiga-Crespo, eds., Wiley & Sons, 2010.
  37. Pathogen eradication by phage therapy in patients with chronic bacterial prostatitis, S.Letkiewicz, R.Międzybrodzki, M.Kłak, B.Weber-Dąbrowska, A.Górski, 25th Annual European Association of Urology Congress, Barcelona, 16-20 April, 2010
    http://www.postersessiononline.com/173580348_eu/congresos/25eau/aula/-P_374_25eau.pdf
  38. Prophylactic effect of bacteriophages on mice subjected to chemotherapy-induced immunosuppression and bone marrow transplant upon infection with Staphylococcus aureus, Michał Zimecki, Jolanta Artym, Maja Kocięba, Beata Weber-Dąbrowska, Jan Borysowski, Andrzej Górski, Med Microbiol Immunol 2010, 199, 71-9
  39. The effects of staphylococcal bacteriophage lysates on cancer cells in vitro, K.Dąbrowska, G.Szkaradziński, A.Kurzępa, B.Owczarek, M.Żaczek, B.Weber-Dąbrowska, J.Wietrzyk, M.Maciejewska, P.Budynek, A.Górski, Clin Exp Med 2010,10,81-85
    http://www.springerlink.com/content/740262658m04n256/
  40. Effects of prophylactic administration of bacteriophages to immunosuppressed mice infected with Staphylococcus aureus, M. Zimecki, J. Artym, M., B. Weber-Dąbrowska, J. Borysowski and A.Górski, BMC Microbiology 2009, 9:169
    http://www.biomedcentral.com/1471-2180/9/169
  41. Bacteriophage therapy for treatment of infections, A.Górski, R.Międzybrodzki, J.Borysowski, B. Weber-Dąbrowska, M. Łobocka , W. Fortuna, S. Letkiewicz, M. Zimecki, G. Filby, Curr Opin Invest Drugs 2009,10,766-74
  42. Antitumor effect of combined treatment of mice with cytostatic agents and bacteriophage T4, Szczaurska-Nowak K, Dabrowska K, Celka M, Kurzepa A, Nevozhay D, Wietrzyk J, Switala-Jelen K, Syper D, Pozniak G, Opolski A, Górski A, Radzikowski C, Anticancer Res. 2009 Jun;29(6):2361-70
  43. Eradication of Enterococcus faecalis by phage therapy in chronic prostatitis, S.Letkiewicz, R.Międzybrodzki, W.Fortuna, B.Weber-Dąbrowska, A.Górski, Folia Microbiol. 2009,54(5),457–461
    http://www.springerlink.com/content/134w262258374308/
  44. Fusion to cell-penetrating peptides will enable lytic enzymes to kill intracellular bacteria, Borysowski J., Górski, A., Medical Hypotheses. 2010,74,164-6
  45. A retrospective analysis of changes in inflammatory markers in patients treated with bacterial viruses, Międzybrodzki R., Fortuna W., Weber-Dąbrowska B., Górski, A., Clin.Exp.Med. 2009,9,303-12
  46. The Effect of Bacteriophages T4 and HAP1 on In Vitro Melanoma Migration, Dąbrowska K., Skaradzinski G., Jończyk P., Aneta Kurzępa A., Wietrzyk J., Owczarek B., Żaczek M., Świtała-Jeleń K., Boratyński J., Poźniak G., Maciejewska M., Górski A., BMC Microbiology 2009,9:13
    http://www.biomedcentral.com/1471-2180/9/13/abstract
  47. Bacteriophage interactions with phagocytes and their potential significance in experimental therapy, Kurzępa A., Dąbrowska K., Skaradziński G., Górski A., Clin Exp Med 2009,9,93-100
  48. Eighty years of phage therapy in Poland: Past, present, and future, Górski A., Weber-Dąbrowska B., Międzybrodzki R., Fortuna W., Dąbrowska K., Letkiewicz S., Edinburgh International Phage Conference, 26-29 July 2008, abstracts p. 15
  49. T4 phage does not induce a strong oxydative burst in peripheral blood neutrophils in mice, Borysowski J., Wierzbicki P., Kłosowska D., Przerwa A., Górski A., Edinburgh International Phage Conference, 26-29 July 2008, abstracts p. 75
  50. Pathogen eradication by phage therapy in patients with chronic bacterial prostatitis, Międzybrodzki R., Letkiewicz S., Górski A., Edinburgh International Phage Conference, 26-29 July 2008, abstracts p. 79
  51. Molecular modification of T4 bacteriophage proteins and its potential application, A. Kurzępa, K. Dąbrowska, K. Świtała-Jeleń, A. Górski, Folia Microbiologica, 2009;54,5-15
  52. The potential of phage therapy in bacterial infections of the eye , Andrzej Górski, Magdalena Targońska, Jan Borysowski, Beata Weber-Dąbrowska, Ophthalmologica 2009;223:162-165
  53. The effect of bacteriophages T4 and HAP1 on in vitro melanoma migration,
    EMBO Meeting: Cellular Signaling and Molecular Medicine, May 29 – Jun 4, 2008, Cavtat/Dubrovnik, Croatia
  54. Bacteriophage therapy in children: facts and prospects, Fortuna W., Międzybrodzki R., Weber-Dąbrowska B., Górski A., Med Sci Monit 2008,14,126-132
  55. Is phage therapy acceptable in the immunocompromised host?, J.Borysowski, A.Górski, Int J Infect Dis 2008,12,466-471
  56. Bacteriophages support anti-tumor response initiated by DC-based vaccine against murine transplantable colon carcinoma, Pajtasz-Piasecka E., Rossowska J., Dus D., Weber-Dabrowska B., Zablocka A., Górski A., Immunology Letters 2008,116,24-32
  57. Bacteriophages decrease activity of NF-kappa B induced in human mononuclear cells by human herpesvirus-1, WA Gorczyca, M.Mitkiewicz, J.Siednienko, E.Kurowska, E.Piasecki, B.Weber-Dąbrowska, A.Górski, In: 13th International Congress of Immunology, Brazil, August 2007. Eds: J.Kalil, E.Cunha-Neto, L.V.Rizzo, Medimond, 2007, p.73-77
  58. Bacteriophage preparation inhibition of reactive oxygen species generation by endotoxin - stimulated polymorphonuclear leukocytes, Międzybrodzki, K.Świtała-Jeleń, W.Fortuna, B.Weber-Dąbrowska, A.Przerwa, M.Łusiak-Szelachowska, K.Dąbrowska, J.Boratyński, D.Syper, G.Późniak, Cz.Ługowski, A.Górski, Virus Res. 2008,131,233-242
  59. Phage therapy of staphylococcal infections (including MRSA) may be less expensive than antibiotic treatment, R.Miedzybrodzki, W. Fortuna, B.Weber-Dąbrowska, A.Górski, Adv.Hyg.Exp.Med. 2007,61,461-465,
    http://www.phmd.pl/modules.php?name=Current_Issue&d_op=summary&id=10883
  60. Bacteriophages in medicine, Andrzej Górski , Jan Borysowski, Ryszard Międzybrodzki, Beata-Weber-Dąbrowska, In: S. McGrath, D. van Sinderen (Eds), Bacteriophage: Genetics and Molecular Biology. Caister Academic Press, 2007, pp. 125-158.
  61. Hoc protein regulates the biological effects of T4 phage in mammals, K.Dąbrowska, M.Zembala, J.Boratyński, K.Świtała-Jeleń, J.Wietrzyk, A.Opolski, K.Szczaurska, M.Kujawa, J.Godlewska, A.Górski, Arch Microbiol. 2007,187,489-98
  62. Befsztyki doprawione wirusem,
    Stany Zjednoczone właśnie postanowiły dodawać do żywności bakteriofagi, dobroczynne wirusy, które stają się konkurencją dla antybiotyków.
  63. Terapia fagowa jako alternatywa w leczeniu zakażeń wywołanych przez bakterie antybiotykooporne, R.Międzybrodzki, J.Borysowski, W.Fortuna, B.Weber-Dąbrowska, A.Górski, Kardiochir. Torakochir. Pol. 2006,3,201-205
  64. Successful eradication of methicillin-resistant Staphylococcus aureus (MRSA) carrier status in a healthcare worker, P.Leszczyński, B.Weber-Dąbrowska, M. Kohutnicka, M.Łuczak, A. Górecki, A. Górski, Folia Microbiol. 2006,51,236-8
  65. Experimental phage therapy in humans as seen from a medical, legal, and administrative perspective, A.Górski, R.Międzybrodzki, B.Weber-Dąbrowska, W.Fortuna, J.Borysowski, 1st Texas/Evergreen Phage/Virus Genomics and Ecology Meeting, Kingsville, TX, USA, 12-16 May 2006. Abstracts, p.12.
  66. Effects of bacteriophages on free radical production and phagocytic functions, Anna Przerwa, Michał Zimecki, Kinga Świtała-Jeleń, Krystyna Dąbrowska, Ewa Krawczyk, Mirosław Łuczak, Beata Weber-Dąbrowska, Danuta Syper, Ryszard Międzybrodzki, Andrzej Górski, Med Microbiol Immunol, 2006,31, 1-8
    http://dx.doi.org/10.1007/s00430-006-0011-4
  67. Bacteriophage endolysins as a novel class of antibacterial agents, J.Borysowski, B.Weber-Dąbrowska, A.Górski, Exp Biol Med, 2006,231,366-77
  68. Bacteriophage translocation, Andrzej Gorski, Ewa Wazna, Beata Weber-Dąbrowska, Krystyna Dąbrowska, Kinga Świtała-Jeleń, Ryszard Międzybrodzki, FEMS Immunology & Medical Microbiology, 2006,46,313-9.
  69. Possible association between phages, Hoc protein, and the immune system, Krystyna Dąbrowska, Kinga Świtała-Jeleń, Adam Opolski, Andrzej Górski, Arch Virol, 2006,151,209-215
  70. Bacteriophages and transplantation tolerance, A.Górski, M.Kniotek, A.Perkowska-Ptasińska, A.Mróz, A.Przerwa, W.Gorczyca, K.Dąbrowska, B.Weber-Dąbrowska, M.Nowaczyk, Transplantation Proc., 2006,38,331-3
  71. Activity of bacteriophages in murine tumour models depends on the route of phage administration, K. Dąbrowska, A. Opolski, J. Wietrzyk, D. Nevozhay, K. Szczaurska, K. Świtala-Jeleń, J. Boratyński, A. Górski, Oncology Research, 2005,15,183-187
  72. Potencjalne zastosowania bakteriofagów w świetle obecnego kryzysu antybiotykoterapii,
    The potential use of bacteriophages in view of the current antibiotic therapy crisis
    ,
    J. Borysowski, B. Weber-Dąbrowska, A. Górski, Pol Arch Int Med 2005,113, 73-8 (in Polish)
  73. Bacterial viruses against viruses pathogenic for man?, R. Międzybrodzki, W. Fortuna, B. Weber-Dąbrowska, A. Górski, Virus Research, 2005,110,1-8
  74. The potential role of endogenous bacteriophages in controlling invading pathogens, A. Górski, B. Weber-Dąbrowska, Cell. Mol. Life Sci., 2005,62,511-519
  75. Bakteriofagi a kryzys antybiotykoterapii, A. Górski, B. Weber-Dąbrowska, J. Borysowski, Medycyna po Dyplomie, 2004, suppl. 21/04, 3-4
  76. Antitumour activity of bacteriophages in murine experimental cancer models caused possibly by inhibition of ß3 integrin signaling pathway, K. Dabrowska, A. Opolski, J. Wietrzyk, K. Switala-Jelen, J. Boratynski, A. Nasulewicz, L. Lipinska, A. Chybicka, M. Kujawa, M. Zabel, B. Dolinska-Krajewska, E. Piasecki, B. Weber-Dabrowska, J. Rybka, J. Salwa, E. Wojdat, M. Nowaczyk, A. Gorski, Acta Virologica, 2004, 48, 241-248
  77. Anticancer activity of bacteriophage T4 and its mutant HAP1 in mouse experimental tumour models, K.Dąbrowska, A.Opolski, J. Wietrzyk, K.Świtała-Jeleń, J.Godlewska, J.Boratyński, D.Syper, B.Weber-Dąbrowska, A.Górski,
    Anticancer Research, 24(6):3991-3995, 2004
  78. Clinical phage therapy: present and future, A. Gorski, B. Weber-Dabrowska, K. Dabrowska, A. Opolski, R. Miedzybrodzki, K. Switala-Jelen, J. Boratynski, M. Nowaczyk, M. Kniotek, P. Wierzbicki,
    American Society for Microbiology Conference on the New Phage Biology, August, 2004, Key Biscayne, USA
  79. Bacteriophage interactions with T cells and platelets, M. Kniotek, AMA Ahmed, K. Dąbrowska, K. Świtała-Jeleń, A. Opolski, A. Górski,
    In: Cytokine Network, Regulatory Cells, Signalling, and Apoptosis (Immunology 2004), p. 189
    Monduzzi Editors, Bologna, Italy.
  80. Phages as Immunomodulators of Antibody Production, M. Kniotek, B. Weber-Dąbrowska, K. Dąbrowska, K. Świtała-Jeleń, J. Boratyński, M. Wiszniowski, W. Glinkowski, I. Babiak, A. Górecki, M. Nowaczyk, A. Górski,
    In: Genomic Issues, Immune System Activation and Allergy (Immunology 2004), p. 33
    Monduzzi Editors, Bologna, Italy.
  81. Perspectives of bacteriophage therapy in urology, A. Gorski, B. Weber-Dabrowska, R. Miedzybrodzki, W. Fortuna, R. Hanecki, Urological Review, 2004,5,8-10 (in Polish)
  82. Bacteriophage penetration in vertebrates, Krystyna Dabrowska, Kinga Switala-Jelen, Beata Weber-Dabrowska, Andrzej Gorski, J. Appl. Microbiol., 2005,98,7-13
  83. Preparation of endotoxin-free bacteriophages, J. Boratyński, D. Syper, B. Weber-Dąbrowska, M. Łusiak-Szelachowska, G. Późniak, A. Górski, Cellular & Molecular Biology Letters, 2004,9,253-259
  84. New insights into the possible role of bacteriophages in transplantation, A.Górski, M.Nowaczyk, B.Weber-Dąbrowska, M.Kniotek, J.Boratyński, A.Ahmed, K.Dąbrowska, P.Wierzbicki, K.Świtała-Jeleń, A.Opolski, Transplantation Proc. 2003,35,2372-2373
  85. Bacteriophages provide regulatory signals in mitogen-induced murine splenocyte proliferation, Michał Zimecki, Beata Weber-Dąbrowska, Marzanna Łusiak-Szelachowska, Marian Mulczyk, Janusz Boratyński, Gryzelda Poźniak, Danuta Syper, Andrzej Górski, Cellular & Molecular Biology Letters, 2003,8,699–711
  86. Computer simulations of phage therapy, A. Zwiefka, B. Weber-Dąbrowska, A. Górski, Adv. Clin. Exp. Med. 2003,12,105-109 (in Polish)
  87. Bacteriophages as an efficient therapy for antibiotic - resistant septicemia in man, Beata Weber-Dabrowska, Marian Mulczyk, Andrzej Górski, Transplantation Proc. 2003,35,1385-1386
  88. New insights into the possible role of bacteriophages in host defense and disease, Andrzej Gorski, Krystyna Dabrowska, Kinga Switala-Jelen, Maria Nowaczyk, Beata Weber-Dabrowska, Janusz Boratynski, Joanna Wietrzyk, Adam Opolski, Medical Immunology 2003, 2:2
  89. Effect of phage therapy on the turnover and function of peripheral neutrophils, B. Weber-Dąbrowska, M. Zimecki, M. Mulczyk, A. Górski, FEMS Immunology and Medical Microbiology, 2002, 34, 135-138
  90. Bacteriophage Inhibits Metastasis in Mouse Transplantable Melanoma Model, Andrzej Gorski, Krystyna Dabrowska, Joanna Wietrzyk, Anna Nasulewicz, Adam Opolski, American Association for Cancer Research: An AACR Special Conference in Cancer Research “Proteases, Extracellular Matrix, and Cancer” 9-13.10.2002 Hilton Head Island, USA, Conference Proceedings: Abstracts of Poster Presentation n. B33
  91. Mutations in bacteriophage T4 genome, K. Świtała-Jeleń, K. Dąbrowska, A. Górski, L. Śliwa, Acta virologica, 2002, 46, 57-62
  92. Therapy of infections in cancer patients with bacteriophages, B. Weber-Dąbrowska, M. Mulczyk, A. Górski, Clin Appl Immunol Rev, 2001, 1, 131
  93. Bacteriophage therapy of bacterial infections: an update of our Institute`s experience, B. Weber-Dąbrowska, M. Mulczyk, A. Górski, Arch. Immunol. Ther. Exp., 2000, 48, 547
  94. Results of bacteriophage treatment of suppurative bacterial infections in the years 1981 - 1986, S. Ślopek, B. Weber-Dąbrowska, M. Dąbrowski, A. Kucharewicz-Krukowska, Arch. Immunol. Ther. Exp., 1987, 35, 569
  95. Results of bacteriophage treatment of suppurative bacterial infections: General Evaluation of the Results, S. Ślopek, I. Durlakowa, B. Weber-Dąbrowska, A. Kucharewicz-Krukowska, M. Dąbrowski, R. Bisikiewicz, Arch. Immunol. Ther. Exp., 1983, 31, 267
  96. Ludwik Hirszfeld, Bakteriofagi i ich rola w rozpoznawaniu duru brzusznego, (Bacteriophages and their role in the diagnosis of typhoid fever)
  97. Ludwik Hirszfeld, Walka świata niewidzialnego z pozawidzialnym, (The battle of the invisible with the imperceptible)